Enhabit (NYSE:EHAB) Conference Transcript

Enhabit (NYSE: EHAB) Conference Call Summary Company Overview - Enhabit is one of the largest home health and hospice providers in the U.S. [2] Key Industry Insights - The final home health rate update from CMS resulted in a better outcome than initially proposed, although it still represents a cut [2][3] - Enhabit anticipates organic profitability growth in 2026 at a similar rate to 2025, despite the negative reimbursement rate [3][5] - The final rule indicates a potential end to permanent behavior adjustments by CMS, which is viewed positively by the company [7][8] Financial Performance and Projections - The company expects to target increased investments in 2026, including de novo openings and strategic M&A, due to improved balance sheet flexibility [4][12] - Temporary adjustments from CMS are projected to recoup approximately $460 million in 2026, with a total over-reimbursement of $4.76 billion anticipated over ten years [10][11] - Approximately 20% of Enhabit's Medicare Advantage (MA) census is linked to Medicare fee-for-service [16] M&A and Investment Strategy - Enhabit plans to be disciplined in M&A, focusing on accretive transactions, particularly in home health, while hospice acquisitions may be more challenging due to high multiples [12][13] - The company is looking to increase de novo investments in hospice, particularly in overlapping markets with home health [13][57] Payer Innovation and Contract Negotiations - 57% of Enhabit's non-Medicare admissions are in payer innovation contracts, up from 52% year-over-year [19] - The company is successfully renegotiating contracts, achieving low double-digit rate increases without significant disruption [21][22] - Enhabit is focusing on moving per-visit contracts towards episodic contracts to better manage patient care [25][26] Market Dynamics and Challenges - Medicare fee-for-service admissions declined by about 3% in Q3, with Enhabit maintaining a mix of 47% Medicare and 53% MA [32][33] - The company is actively working to improve its fee-for-service mix through partnerships and community care initiatives [34][36] Cost Management and Labor - Enhabit expects a decline in cost per day due to increased volume and fixed salary costs [37] - Wage inflation is projected to remain around 3% for both home health and hospice [38][46] Growth Projections - Long-term growth for both home health and hospice is expected to be in the mid to high single digits [43][49] - The hospice segment has seen robust growth, with 25% of hospice admissions coming from home health [59] Corporate Financial Health - Enhabit exited the quarter with a leverage ratio of 3.9, with plans to maintain flexibility while pursuing targeted acquisitions [60][61] - The company aims to balance free cash flow deployment with deleveraging efforts [62] Conclusion - Enhabit is positioned for growth through strategic investments, disciplined M&A, and a focus on improving profitability despite regulatory challenges in the home health and hospice sectors [4][12][60]